Literature DB >> 19280102

Depression and psychiatric symptoms preceding onset of dementia in a family with early-onset Alzheimer disease with a novel PSEN1 mutation.

Kensaku Kasuga, Tsukasa Ohno, Tomohiko Ishihara, Akinori Miyashita, Ryozo Kuwano, Osamu Onodera, Masatoyo Nishizawa, Takeshi Ikeuchi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19280102     DOI： 10.1007/s00415-009-5096-4

Source DB:  PubMed          Journal:  J Neurol        ISSN： 0340-5354            Impact factor:   4.849


× No keyword cloud information.
  10 in total

1.  A presenilin-1 mutation (Leu392Pro) in a familial AD kindred with psychiatric symptoms at onset.

Authors:  A Tedde; P Forleo; B Nacmias; C Piccini; L Bracco; S Piacentini; S Sorbi
Journal:  Neurology       Date:  2000-11-28       Impact factor: 9.910

2.  Familial Alzheimer disease-linked presenilin 1 variants enhance production of both Abeta 1-40 and Abeta 1-42 peptides that are only partially sensitive to a potent aspartyl protease transition state inhibitor of "gamma-secretase".

Authors:  Takeshi Ikeuchi; Georgia Dolios; Seong-Hun Kim; Rong Wang; Sangram S Sisodia
Journal:  J Biol Chem       Date:  2002-12-19       Impact factor: 5.157

3.  Mutational analysis in early-onset familial dementia in the Japanese population. The role of PSEN1 and MAPT R406W mutations.

Authors:  Takeshi Ikeuchi; Hiroyuki Kaneko; Akinori Miyashita; Hiroaki Nozaki; Kensaku Kasuga; Tamao Tsukie; Miyuki Tsuchiya; Toru Imamura; Hideki Ishizu; Kenju Aoki; Atsushi Ishikawa; Osamu Onodera; Ryozo Kuwano; Masatoyo Nishizawa
Journal:  Dement Geriatr Cogn Disord       Date:  2008-06-28       Impact factor: 2.959

4.  Screening for PS1 mutations in a referral-based series of AD cases: 21 novel mutations.

Authors:  E A Rogaeva; K C Fafel; Y Q Song; H Medeiros; C Sato; Y Liang; E Richard; E I Rogaev; P Frommelt; A D Sadovnick; W Meschino; K Rockwood; M A Boss; R Mayeux; P St George-Hyslop
Journal:  Neurology       Date:  2001-08-28       Impact factor: 9.910

5.  Diagnostic accuracy of mini-mental status examination and revised hasegawa dementia scale for Alzheimer's disease.

Authors:  K W Kim; D Y Lee; J H Jhoo; J C Youn; Y J Suh; Y H Jun; E H Seo; J I Woo
Journal:  Dement Geriatr Cogn Disord       Date:  2005-03-22       Impact factor: 2.959

6.  Chromosome 14 familial Alzheimer's disease: the clinical and neuropathological characteristics of a family with a leucine-->serine (L250S) substitution at codon 250 of the presenilin 1 gene.

Authors:  R J Harvey; D Ellison; J Hardy; M Hutton; P K Roques; J Collinge; N C Fox; M N Rossor
Journal:  J Neurol Neurosurg Psychiatry       Date:  1998-01       Impact factor: 10.154

7.  Molecular diagnosis of autosomal dominant early onset Alzheimer's disease: an update.

Authors:  G Raux; L Guyant-Maréchal; C Martin; J Bou; C Penet; A Brice; D Hannequin; T Frebourg; D Campion
Journal:  J Med Genet       Date:  2005-07-20       Impact factor: 6.318

8.  Female preclinical presenilin-1 mutation carriers unaware of their genetic status have higher levels of depression than their non-mutation carrying kin.

Authors:  J M Ringman; C Diaz-Olavarrieta; Y Rodriguez; M Chavez; F Paz; J Murrell; M Angel Macias; M Hill; C Kawas
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-03       Impact factor: 10.154

9.  Enhanced accumulation of phosphorylated alpha-synuclein and elevated beta-amyloid 42/40 ratio caused by expression of the presenilin-1 deltaT440 mutant associated with familial Lewy body disease and variant Alzheimer's disease.

Authors:  Hiroyuki Kaneko; Akiyoshi Kakita; Kensaku Kasuga; Hiroaki Nozaki; Atsushi Ishikawa; Akinori Miyashita; Ryozo Kuwano; Genta Ito; Takeshi Iwatsubo; Hitoshi Takahashi; Masatoyo Nishizawa; Osamu Onodera; Sangram S Sisodia; Takeshi Ikeuchi
Journal:  J Neurosci       Date:  2007-11-28       Impact factor: 6.167

Review 10.  Clinical phenotypic heterogeneity of Alzheimer's disease associated with mutations of the presenilin-1 gene.

Authors:  A J Larner; M Doran
Journal:  J Neurol       Date:  2005-11-04       Impact factor: 6.682
  10 in total
  9 in total

1.  Posttraumatic stress disorder-like induction elevates β-amyloid levels, which directly activates corticotropin-releasing factor neurons to exacerbate stress responses.

Authors:  Nicholas J Justice; Longwen Huang; Jin-Bin Tian; Allysa Cole; Melissa Pruski; Albert J Hunt; Rene Flores; Michael X Zhu; Benjamin R Arenkiel; Hui Zheng
Journal:  J Neurosci       Date:  2015-02-11       Impact factor: 6.167

2.  Hyperphosphorylation of Tau induced by naturally secreted amyloid-β at nanomolar concentrations is modulated by insulin-dependent Akt-GSK3β signaling pathway.

Authors:  Takayoshi Tokutake; Kensaku Kasuga; Ryuji Yajima; Yumi Sekine; Toshiyuki Tezuka; Masatoyo Nishizawa; Takeshi Ikeuchi
Journal:  J Biol Chem       Date:  2012-08-21       Impact factor: 5.157

3.  Central CRF system perturbation in an Alzheimer's disease knockin mouse model.

Authors:  Qinxi Guo; Hui Zheng; Nicholas John Justice
Journal:  Neurobiol Aging       Date:  2012-02-14       Impact factor: 4.673

Review 4.  Mutations, associated with early-onset Alzheimer's disease, discovered in Asian countries.

Authors:  Eva Bagyinszky; Young Chul Youn; Seong Soo A An; SangYun Kim
Journal:  Clin Interv Aging       Date:  2016-10-17       Impact factor: 4.458

5.  A pathogenic PSEN1 Trp165Cys mutation associated with early-onset Alzheimer's disease.

Authors:  Vo Van Giau; Jung-Min Pyun; Jeewon Suh; Eva Bagyinszky; Seong Soo A An; Sang Yun Kim
Journal:  BMC Neurol       Date:  2019-08-07       Impact factor: 2.474

6.  APP, PSEN1, and PSEN2 Mutations in Asian Patients with Early-Onset Alzheimer Disease.

Authors:  Vo Van Giau; Eva Bagyinszky; Young Chul Youn; Seong Soo A An; SangYun Kim
Journal:  Int J Mol Sci       Date:  2019-09-25       Impact factor: 5.923

7.  Pooled-DNA sequencing identifies novel causative variants in PSEN1, GRN and MAPT in a clinical early-onset and familial Alzheimer's disease Ibero-American cohort.

Authors:  Sheng Chih Jin; Pau Pastor; Breanna Cooper; Sebastian Cervantes; Bruno A Benitez; Cristina Razquin; Alison Goate; Carlos Cruchaga
Journal:  Alzheimers Res Ther       Date:  2012-08-20       Impact factor: 6.982

Review 8.  The genetics of Alzheimer's disease.

Authors:  Eva Bagyinszky; Young Chul Youn; Seong Soo A An; SangYun Kim
Journal:  Clin Interv Aging       Date:  2014-04-01       Impact factor: 4.458

9.  Whole-Exome Sequencing in Searching for New Variants Associated With the Development of Parkinson's Disease.

Authors:  Marina V Shulskaya; Anelya Kh Alieva; Ivan N Vlasov; Vladimir V Zyrin; Ekaterina Yu Fedotova; Natalia Yu Abramycheva; Tatiana S Usenko; Andrei F Yakimovsky; Anton K Emelyanov; Sofya N Pchelina; Sergei N Illarioshkin; Petr A Slominsky; Maria I Shadrina
Journal:  Front Aging Neurosci       Date:  2018-05-15       Impact factor: 5.750
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.